You have 9 free searches left this month | for more free features.

PA-824

Showing 1 - 25 of 1,222

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)

Completed
  • Pulmonary Tuberculosis
  • PA-824
  • +5 more
  • Cape Town, South Africa
    University of Cape Town Lung Institute
May 18, 2022

Tuberculosis Trial in United States (PA-824, Efavirenz (EFV), Lopinavir/Ritonavir (LPV/r))

Completed
  • Tuberculosis
  • PA-824
  • +3 more
  • San Francisco, California
  • +3 more
Nov 4, 2021

Tuberculosis Trial in Saint Louis, Durham (PA-824)

Recruiting
  • Tuberculosis
  • PA-824
  • Saint Louis, Missouri
  • +1 more
Aug 11, 2022

Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)

Completed
  • Pulmonary Tuberculosis
  • Ysterplaat, Cape Town, South Africa
  • +2 more
Nov 19, 2020

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

Recruiting
  • Tuberculosis, Pulmonary
  • +4 more
  • Johannesburg, South Africa
  • +2 more
Oct 4, 2021

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

Active, not recruiting
  • Tuberculosis, Pulmonary
  • +5 more
  • Tbilisi, Georgia
  • +10 more
Jan 26, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Multidrug Resistant Tuberculosis Trial in Belarus, South Africa, Uzbekistan (Bedaquiline, Pretomanid, Moxifloxacin)

Recruiting
  • Multidrug Resistant Tuberculosis
  • Minsk, Belarus
  • +5 more
May 12, 2021

Pulmonary Tuberculosis Trial (PA-824, Rifafour e-275 mg)

Completed
  • Pulmonary Tuberculosis
  • PA-824
  • Rifafour e-275 mg
  • (no location specified)
Sep 4, 2019

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

Active, not recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +4 more
May 12, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South

Recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Tuberculosis Trial in Lincoln (Midazolam, PA-824)

Completed
  • Tuberculosis
  • Lincoln, Nebraska
    MDS Pharma Services
Sep 10, 2019

Tuberculosis Trial in Lincoln (PA-824 200mg, PA-824 50mg)

Completed
  • Tuberculosis
  • PA-824 200mg
  • PA-824 50mg
  • Lincoln, Nebraska
    MDS Pharma Services (Celerion)
Sep 4, 2019

Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Multi-drug Resistant Tuberculosis Trial in San Antonio (Pretomanid)

Completed
  • Multi-drug Resistant Tuberculosis
  • San Antonio, Texas
    Worldwide Clinical Trials Early Phase Services, LLC
Mar 13, 2020

Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)

Completed
  • Tuberculosis
  • PA-824
  • +4 more
  • Tembisa, Gauteng, South Africa
  • +9 more
May 28, 2019

Tuberculosis Trial in Madison (PA-824)

Completed
  • Tuberculosis
  • PA-824
  • Madison, Wisconsin
    Covance Clinical Research Unit
Aug 1, 2018

Tuberculosis, Pulmonary, Drug Sensitive, Tuberculosis, Pulmonary, Multi Drug-resistant Trial in Worldwide (Moxifloxacin, PA-824,

Completed
  • Tuberculosis, Pulmonary, Drug Sensitive
  • Tuberculosis, Pulmonary, Multi Drug-resistant
  • Tbilisi, Georgia
  • +25 more
Mar 1, 2019

Nonvalvular Atrial Fibrillation, Health, Subjective Trial in Beijing (Dabigatran etexilate capsule)

Recruiting
  • Nonvalvular Atrial Fibrillation
  • Health, Subjective
  • Dabigatran etexilate capsule
  • Beijing, China
    Peking University Third Hospital
Feb 6, 2023

Pulmonary Tuberculosis Trial in South Africa, Tanzania (Moxifloxacin (M), Pretomid (Pa), Pyrazinamide (Z))

Completed
  • Pulmonary Tuberculosis
  • Moxifloxacin (M)
  • +3 more
  • Cape Town, South Africa
  • +7 more
May 16, 2018

Biliary Atresia Trial in Houston (Pentoxifylline)

Recruiting
  • Biliary Atresia
  • Houston, Texas
    Texas Children's Hospital and Baylor College of Medicine
Feb 1, 2023

Cystic Fibrosis, Sickle Cell Disease, SARS CoV 2 Infection Trial in Irvine (Exercise)

Recruiting
  • Cystic Fibrosis
  • +2 more
  • Exercise
  • Irvine, California
    University of California, Irvine
Jan 5, 2023

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Scottsdale (Best Practice, Exercise Counseling, Exercise

Not yet recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Best Practice
  • +5 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Oct 12, 2023

Association Between Primary Aldosteronism and Thyroid Cancer

Completed
  • Thyroid Cancer, Papillary
  • Primary Aldosteronism
  • Secreening test for primary aldosteronism and Confirmatory Testing
  • São Paulo, Brazil
    Ana Alice Wolf Maciel
Oct 3, 2023